Reset Pharmaceuticals, Inc. — Form D
Reset Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-25. The offering totals $12.7M, of which $11.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-02-25
- Form: D
- Accession: 0001905880-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.7M
- Amount sold: $11.1M
- Remaining: $1.6M
- Minimum investment: $25K
- Investors: 26
- Date of first sale: 2021-11-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435097
Issuer
- Name: Reset Pharmaceuticals, Inc.
- CIK: 0001905880
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 241 CENTRAL PARK W APT 9A, NEW YORK, NY, 10024
- Phone: 646-342-2583
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| John Andreadis | Director | New York, NY |
| Jan-Anders Karlsson | Director | New York, NY |
| Tim Schlidt | Director | New York, NY |
| Philip Taub | Director | Coral Gables, FL |
| John Andreadis | Executive Officer | New York, NY |
| Jan-Anders Karlsson | Executive Officer | New York, NY |
More